Jean‐Christophe Ianotto

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

Gabriel Étienne, Joëlle Guilhot, Delphine Réa et al. · Journal of Clinical Oncology · 2016 · 484 citations

Hematological Malignancy, Stop Imatinib, Chronic Myeloid Leukemia +14

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer et al. · Journal of Clinical Oncology · 2012 · 441 citations · Full text

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Delphine Réa, Franck E. Nicolini, Michel Tulliez et al. · Blood · 2016 · 314 citations · Full text

Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients

Xénia Cabagnols, Fabrizia Favale, Florence Pasquier et al. · Blood · 2015 · 182 citations · Full text

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations

Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau et al. · Blood · 2015 · 154 citations · Full text